These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 14558982)

  • 1. Trials in isolated systolic hypertension: an update.
    Waeber B
    Curr Cardiol Rep; 2003 Nov; 5(6):427-34. PubMed ID: 14558982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trials in isolated systolic hypertension: an update.
    Waeber B
    Curr Hypertens Rep; 2003 Aug; 5(4):329-36. PubMed ID: 12844468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group.
    Curb JD; Pressel SL; Cutler JA; Savage PJ; Applegate WB; Black H; Camel G; Davis BR; Frost PH; Gonzalez N; Guthrie G; Oberman A; Rutan GH; Stamler J
    JAMA; 1996 Dec; 276(23):1886-92. PubMed ID: 8968014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk reduction associated with lowering systolic blood pressure: review of clinical trial data.
    Hall WD
    Am Heart J; 1999 Sep; 138(3 Pt 2):225-30. PubMed ID: 10467217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolated systolic hypertension: pathophysiology, consequences and therapeutic benefits.
    Kocemba J; Kawecka-Jaszcz K; Gryglewska B; Grodzicki T
    J Hum Hypertens; 1998 Sep; 12(9):621-6. PubMed ID: 9783491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treating isolated systolic hypertension in the elderly.
    Howard PA
    Ann Pharmacother; 1994 Mar; 28(3):367-73. PubMed ID: 8193428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of isolated systolic hypertension in the elderly: further evidence from the systolic hypertension in Europe (Syst-Eur) trial.
    Staessen JA; Thijs L; Gasowski J; Cells H; Fagard RH
    Am J Cardiol; 1998 Nov; 82(9B):20R-22R. PubMed ID: 9822139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of calcium channel antagonists for the treatment of hypertension in the elderly.
    Steffen HM
    Drugs Aging; 2004; 21(9):565-81. PubMed ID: 15260512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
    Evid Based Child Health; 2014 Sep; 9(3):498-580. PubMed ID: 25236305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2.
    Ekbom T; Linjer E; Hedner T; Lanke J; De Faire U; Wester PO; Dahlöf B; Scherstén B
    Blood Press; 2004; 13(3):137-41. PubMed ID: 15223721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of isolated systolic hypertension.
    Stokes GS
    Curr Hypertens Rep; 2006 Oct; 8(5):377-83. PubMed ID: 16965723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of angiotensin II type 1 receptor antagonists in elderly patients with hypertension.
    Thomas GN; Chan P; Tomlinson B
    Drugs Aging; 2006; 23(2):131-55. PubMed ID: 16536636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial of cardiovascular events in hypertension. Rationale and design.
    Mann J; Julius S
    Blood Press; 1998 May; 7(3):176-83. PubMed ID: 9758088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and implications of uncontrolled systolic hypertension.
    Kannel WB
    Drugs Aging; 2003; 20(4):277-86. PubMed ID: 12641483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of isolated systolic hypertension on normalization of left ventricular structure during antihypertensive treatment (the LIFE study).
    Mancusi C; Gerdts E; De Simone G; Abdelhai YM; Lønnebakken MT; Boman K; Wachtell K; Dahlöf B; Devereux RB
    Blood Press; 2014 Aug; 23(4):206-12. PubMed ID: 24564262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cochrane in context: pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh RS
    Evid Based Child Health; 2014 Sep; 9(3):581-3. PubMed ID: 25236306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stroke prevention with the angiotensin II type 1-receptor blocker candesartan in elderly patients with isolated systolic hypertension: the Study on Cognition and Prognosis in the Elderly (SCOPE).
    Papademetriou V; Farsang C; Elmfeldt D; Hofman A; Lithell H; Olofsson B; Skoog I; Trenkwalder P; Zanchetti A;
    J Am Coll Cardiol; 2004 Sep; 44(6):1175-80. PubMed ID: 15364316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: a Losartan Intervention for Endpoint Reduction (LIFE) substudy.
    Kjeldsen SE; Dahlöf B; Devereux RB; Julius S; Aurup P; Edelman J; Beevers G; de Faire U; Fyhrquist F; Ibsen H; Kristianson K; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Snapinn S; Wedel H;
    JAMA; 2002 Sep; 288(12):1491-8. PubMed ID: 12243636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current recommendations for the treatment of hypertension: are they still valid?
    Moser M
    J Hypertens Suppl; 2002 Feb; 20(1):S3-10. PubMed ID: 11996197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [When can the treatment of isolated systolic hypertension be avoided?].
    Vischer UM; Benetos A
    Rev Med Suisse; 2006 Apr; 2(60):942-6. PubMed ID: 16673726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.